Key result
Deferring pre-TAVI invasive angiography via CT shows no difference in 5-year MACE.
Why the study?
In elderly and comorbid TAVI candidates, the safety and accuracy of cCTA as an alternative to ICA for ruling out obstructive CAD remain to be established.
Does a cCTA-based strategy safely rule out obstructive CAD and defer invasive coronary angiography without compromising 5-year clinical outcomes in elderly, high-risk patients undergoing TAVI?
Observational (n=210)
No
Does a cCTA-based strategy safely rule out obstructive CAD and defer invasive coronary angiography without compromising 5-year clinical outcomes in elderly, high-risk patients undergoing TAVI?
Absolute Event Rate: 44.7% vs 46.2%
p-value: p=0.838
A cCTA-first strategy is a safe and effective gatekeeper for ruling out obstructive CAD in elderly TAVI candidates, allowing deferral of invasive angiography in over 60% of patients without negatively impacting 5-year clinical outcomes.
Supports cCTA-guided ICA deferral in TAVI candidates; leaves open need for randomized confirmation before practice change.
Background: Coronary computed tomography angiography (cCTA) is now indicated as a non-invasive tool for ruling out obstructive coronary artery disease (O-CAD) in patients who are candidates for transcatheter aortic valve implantation (TAVI) showing low-intermediate pre-test probability of O-CAD. In elderly and comorbid TAVI candidates, the safety and accuracy of cCTA as an alternative to invasive coronary angiography (ICA) for ruling out O-CAD remain to be established. Aim: To assess the feasibility, diagnostic accuracy, and clinical safety of cCTA for ruling out proximal O-CAD in elderly, comorbid, high-risk patients undergoing TAVI. Methods: We conducted a retrospective, single-center study including all consecutive patients with severe symptomatic aortic stenosis who underwent TAVI between January 2019 and December 2020. All patients underwent pre-TAVI cCTA. Patients with positive or non-diagnostic cCTA underwent ICA selectively (ICA group). In patients with no-O-CAD, ICA was omitted and proceeded directly to TAVI (no-ICA group). Accordingly, patients were divided into two groups: no-ICA and ICA group. Clinical follow-up was extended up to 5 years, with assessment of major adverse cardiovascular events (MACEs), mortality, heart failure hospitalizations, and unplanned revascularization. Results: Among 355 patients enrolled, 210 were included in the study. Among them, 140 (66.7%) had negative cCTA for O-CAD, and ICA was safely omitted in 132 patients (62.8%). cCTA was inconclusive in 43 patients (20.5%) and positive in 27 (12.9%). ICA confirmed O-CAD in 53 of 78 patients (67.9%) and PCI was performed in 35 of 53 (66.0%). The accuracy of cCTA for ruling in O-CAD was low (66.28%). During the follow-up period (1513 ± 508 days), the no-ICA group showed comparable outcomes to the ICA group in terms of periprocedural complications and long-term results—at both 1 and 5 years—for MACEs, heart failure hospitalizations, mortality and unplanned revascularization. Outcomes remain comparable between the two groups after performing matched-pair analyses. Conclusions: Our data show that cCTA may provide a reliable, safe, and effective alternative to ICA for ruling out obstructive CAD in elderly patients undergoing TAVI when image quality is diagnostic. A cCTA-based strategy allows deferral of ICA in most cases without compromising procedural safety or long-term clinical outcomes, enabling a personalized and tailored clinical pathway. Whether advanced CT techniques, such as CT-FFR and photon-counting CT, may help refine patient selection for invasive coronary assessment remains to be demonstrated.
No takes yet. Share an insight, caveat, or question.
Amico et al. (2026) conducted an observational in Severe symptomatic aortic stenosis (n=210). Omission of invasive coronary angiography (no-ICA) based on cCTA vs. Invasive coronary angiography (ICA) was evaluated on Major adverse cardiovascular events (MACE) at 5-year follow-up (p=0.838). Deferring invasive coronary angiography based on non-obstructive coronary artery disease findings on pre-procedural CT angiography resulted in similar 5-year rates of major adverse cardiovascular events compared to patients undergoing invasive evaluation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: